Latest filings (excl ownership)
15-12G
Securities registration termination
17 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Oct 22
POSASR
Automatic shelf registration (post-effective amendment)
5 Oct 22
POSASR
Automatic shelf registration (post-effective amendment)
5 Oct 22
POSASR
Automatic shelf registration (post-effective amendment)
5 Oct 22
8-K
Entry into a Material Definitive Agreement
5 Oct 22
25-NSE
Exchange delisting
5 Oct 22
8-K
Submission of Matters to a Vote of Security Holders
30 Sep 22
8-K
Other Events
23 Sep 22
DEFA14A
Additional proxy soliciting materials
23 Sep 22
DEFA14A
Additional proxy soliciting materials
12 Sep 22
DEFA14A
Additional proxy soliciting materials
31 Aug 22
DEFM14A
Proxy related to merger
29 Aug 22
DEFA14A
Additional proxy soliciting materials
23 Aug 22
PREM14A
Preliminary proxy related to merger
19 Aug 22
DEFA14A
Additional proxy soliciting materials
18 Aug 22
DEFA14A
Additional proxy soliciting materials
18 Aug 22
DEFA14A
Additional proxy soliciting materials
10 Aug 22
DEFA14A
Additional proxy soliciting materials
8 Aug 22
DEFA14A
Additional proxy soliciting materials
8 Aug 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
8-K
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Proposed acquisition drives growth by bringing leading sickle cell disease expertise, portfolio
8 Aug 22
8-K
Other Events
26 Jul 22
8-K
Other Events
14 Jul 22
8-K
Phase 2 portion designed to identify the optimal dose for the pivotal Phase 3 portion of the trial
29 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 22
8-K
New GBT Multinational Survey Shines a Needed Light on the Misunderstood Realities, Unseen Burden and Care Challenges of Sickle Cell Disease
13 Jun 22
8-K
GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease
10 Jun 22
8-K
GBT’s Inclacumab and GBT601 Receive U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for the Treatment of Sickle Cell Disease
6 Jun 22
8-K
GBT Announces Five Data Presentations on Sickle Cell Disease at Upcoming EHA2022 Congress
12 May 22
Latest ownership filings
SC 13G/A
Deep Track Capital, LP
14 Feb 23
SC 13G/A
FMR LLC
9 Feb 23
4
MARK L PERRY
6 Oct 22
4
DEVAL L PATRICK
6 Oct 22
4
Scott W Morrison
6 Oct 22
4
Alexis A. Thompson
6 Oct 22
4
WENDY L YARNO
6 Oct 22
4
Philip A. Pizzo
6 Oct 22
4
Dawn Svoronos
6 Oct 22
4
GLENN PIERCE
6 Oct 22
4
Kim Smith-Whitley
6 Oct 22
4
DAVID LEE JOHNSON
6 Oct 22
4
Jung Choi
6 Oct 22
4
TED W LOVE
6 Oct 22
4
Nazila Habibizad
6 Oct 22
4
Carrie Krehlik
6 Oct 22
4
Jeffrey S Farrow
6 Oct 22
4
TRICIA BORGA SUVARI
6 Oct 22
4
Nazila Habibizad
4 Oct 22
4
Jeffrey S Farrow
29 Sep 22
4
Nazila Habibizad
29 Sep 22
4
TED W LOVE
29 Sep 22
4
Jung Choi
29 Sep 22
4
Nazila Habibizad
6 Sep 22
4
DAVID LEE JOHNSON
6 Sep 22
4
Kim Smith-Whitley
6 Sep 22
4
Carrie Krehlik
6 Sep 22
4
TED W LOVE
6 Sep 22
4
Jeffrey S Farrow
6 Sep 22
4
Jung Choi
6 Sep 22
4
TRICIA BORGA SUVARI
6 Sep 22
4
Nazila Habibizad
19 Aug 22
4
TRICIA BORGA SUVARI
3 Aug 22
4
Nazila Habibizad
3 Aug 22
4
TED W LOVE
3 Aug 22
4
Jung Choi
3 Aug 22
4
DAVID LEE JOHNSON
3 Aug 22
4
Jeffrey S Farrow
3 Aug 22
3/A
Nazila Habibizad
3 Aug 22
4
Philip A. Pizzo
22 Jun 22